Henry M. Jackson Foundation for the Advancement of Military Medicine
The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) is dedicated to advancing military medicine through research and innovation. For over 40 years, HJF has been a trusted partner in managing research awards, ensuring compliance, and facilitating the transition of medical innovations from concept to commercialization. The foundation supports a wide range of research areas, including infectious diseases, cancer, and mental health, with a focus on improving the health and readiness of military personnel and civilians alike.
Industries
Nr. of Employees
Very Large (1000+)
Henry M. Jackson Foundation for the Advancement of Military Medicine
6720A Rockledge Drive, Bethesda, Maryland 20817
Awards
Fiscal Year 2024 Military Prototype Advancement Initiative (MPAI)
Development of a pilot clinical trial capability supporting monitored emergency use of Interleukin-7 (IL-7) for treatment of combat casualty-driven infections in Ukraine
Funding (ceiling)
$4,400,176.9
Award Year
2024
Fiscal Year 2024 Military Prototype Advancement Initiative (MPAI)
Establishment of a Blast-Dose related clinical thresholds scale to guide strategies for prevention, resilience, and recovery of traumatic brain injury in the training and combat environment
Funding (ceiling)
$6,452,847.97
Award Year
2024
Better Together: A primary prevention intervention targeting transdiagnostic interpersonal emotion regulation among military couples
Funding (ceiling)
$1,365,742.37
Award Year
2021
Hemorrhage Detection Technology
Implementation and Evaluation of the APPRAISE Algorithm for Hemorrhage Prediction & Detection
Funding (ceiling)
$977,918.74
Award Year
2020
Solutions to Accelerate Return-to-Readiness following Musculoskeletal Injuries
Dynamic Gait-Synchronous Neuromuscular Electrical Stimulation Following Anterior Cruciate Ligament Reconstruction
Funding (ceiling)
$1,277,563.33
Award Year
2023
Products
Predictive tool for probability of successful wound closure
Algorithmic tool that estimates probability of successful traumatic wound closure based on immuno-molecular status of healing tissue.
Small molecule therapeutics for acute myeloid leukemia and solid tumors
Small-molecule methods and compounds for treating myeloid neoplasms and solid tumors available for licensing or collaborative development.
Diagnostic tool for high-grade serous ovarian cancer
Biomarker-based diagnostic combining protein and transcript signatures correlated with homologous recombination deficiency.
Vascular shunting and anastomosis surgical simulator
Hands-on surgical simulator for training techniques in vascular shunt placement and anastomosis to support life- and limb-saving procedures.
Predictive tool for probability of successful wound closure
Algorithmic tool that estimates probability of successful traumatic wound closure based on immuno-molecular status of healing tissue.
Small molecule therapeutics for acute myeloid leukemia and solid tumors
Small-molecule methods and compounds for treating myeloid neoplasms and solid tumors available for licensing or collaborative development.
Diagnostic tool for high-grade serous ovarian cancer
Biomarker-based diagnostic combining protein and transcript signatures correlated with homologous recombination deficiency.
Vascular shunting and anastomosis surgical simulator
Hands-on surgical simulator for training techniques in vascular shunt placement and anastomosis to support life- and limb-saving procedures.
Expertise Areas
- Clinical trial management
- Infectious disease research and vaccine development
- Global health and international research operations
- Clinical laboratory diagnostics and biorepository management
Key Technologies
- High-resolution slide scanning and digital pathology
- Artificial intelligence and machine learning for diagnostic imaging
- Natural language processing for medical record search
- Monoclonal antibody discovery and development
Key People
Deputy Director, Business Development
Senior Director, Business Development
President & CEO
Chief Operating Officer, Executive Vice President
Strategic Initiatives, Senior Vice President
General Counsel and Secretary, Senior Vice President
Deputy Director, Business Development
Senior Director, Business Development
President & CEO
Chief Operating Officer, Executive Vice President
Strategic Initiatives, Senior Vice President
General Counsel and Secretary, Senior Vice President
News & Updates
The Heroes of Military Medicine (HMM) Awards honor outstanding contributions by individuals who demonstrate excellence and selfless dedication to advance military medicine.
An article about Arnaud Belard's role as Vice President of Enterprise Optimization at HJF.
An article discussing the ARPA-H Award received by HJF.
An article about Dr. Raquel Bono joining HJF's Council of Directors as the new chair.
The Heroes of Military Medicine (HMM) Awards honor outstanding contributions by individuals who demonstrate excellence and selfless dedication to advance military medicine.
An article about Arnaud Belard's role as Vice President of Enterprise Optimization at HJF.
An article discussing the ARPA-H Award received by HJF.
An article about Dr. Raquel Bono joining HJF's Council of Directors as the new chair.